527 related articles for article (PubMed ID: 10922074)
1. Positron emission tomography provides molecular imaging of biological processes.
Phelps ME
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9226-33. PubMed ID: 10922074
[TBL] [Abstract][Full Text] [Related]
2. PET: the merging of biology and imaging into molecular imaging.
Phelps ME
J Nucl Med; 2000 Apr; 41(4):661-81. PubMed ID: 10768568
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of positron emission tomography in diagnosis and treatment follow-up of brain tumors.
Schaller B
Neurobiol Dis; 2004 Apr; 15(3):437-48. PubMed ID: 15056451
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging of brain tumors personal experience and review of the literature.
Schaller BJ; Cornelius JF; Sandu N; Buchfelder M
Curr Mol Med; 2008 Dec; 8(8):711-26. PubMed ID: 19075670
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging of brain tumors: a bridge between clinical and molecular medicine?
Schaller BJ; Modo M; Buchfelder M
Mol Imaging Biol; 2007; 9(2):60-71. PubMed ID: 17203238
[TBL] [Abstract][Full Text] [Related]
7. PET-based molecular imaging in neuroscience.
Jacobs AH; Li H; Winkeler A; Hilker R; Knoess C; Rüger A; Galldiks N; Schaller B; Sobesky J; Kracht L; Monfared P; Klein M; Vollmar S; Bauer B; Wagner R; Graf R; Wienhard K; Herholz K; Heiss WD
Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1051-65. PubMed ID: 12764552
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer.
Berger F; Gambhir SS
Breast Cancer Res; 2001; 3(1):28-35. PubMed ID: 11250742
[TBL] [Abstract][Full Text] [Related]
9. Current molecular imaging of spinal tumors in clinical practice.
Sandu N; Pöpperl G; Toubert ME; Spiriev T; Arasho B; Orabi M; Schaller B
Mol Med; 2011; 17(3-4):308-16. PubMed ID: 21210073
[TBL] [Abstract][Full Text] [Related]
10. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.
Facey K; Bradbury I; Laking G; Payne E
Health Technol Assess; 2007 Oct; 11(44):iii-iv, xi-267. PubMed ID: 17999839
[TBL] [Abstract][Full Text] [Related]
11. PET in oncology: will it replace the other modalities?
Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME
Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854
[TBL] [Abstract][Full Text] [Related]
12. Imaging gene expression and endogenous molecular processes: molecular imaging.
Blasberg R
J Cereb Blood Flow Metab; 2002 Oct; 22(10):1157-64. PubMed ID: 12368652
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
[TBL] [Abstract][Full Text] [Related]
14. [Biomedical imaging in pharmacology with nuclear medical imaging methodologies: positron emission tomography (PET) and single photon emission computed tomography (SPECT)].
Saji H; Iida Y
Nihon Yakurigaku Zasshi; 2003 Mar; 121(3):181-91. PubMed ID: 12673952
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography imaging of regional cerebral glucose metabolism.
Alavi A; Dann R; Chawluk J; Alavi J; Kushner M; Reivich M
Semin Nucl Med; 1986 Jan; 16(1):2-34. PubMed ID: 2935938
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract][Full Text] [Related]
17. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
[TBL] [Abstract][Full Text] [Related]
18. Future direction of renal positron emission tomography.
Szabo Z; Xia J; Mathews WB; Brown PR
Semin Nucl Med; 2006 Jan; 36(1):36-50. PubMed ID: 16356795
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.
Pennant M; Takwoingi Y; Pennant L; Davenport C; Fry-Smith A; Eisinga A; Andronis L; Arvanitis T; Deeks J; Hyde C
Health Technol Assess; 2010 Oct; 14(50):1-103. PubMed ID: 21044553
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of positron emission tomography for the detection of melanoma metastases.
Holder WD; White RL; Zuger JH; Easton EJ; Greene FL
Ann Surg; 1998 May; 227(5):764-9; discussion 769-71. PubMed ID: 9605668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
